Taiwan Dr Hung-Kai Kevin Chen, co-founder and CEO of Elixiron Immunotherapeutics, an innovative rising biotech focused on immunotherapeutic solutions, describes the company’s unique approach to developing new treatment methods for two disease areas with massive unmet medical need: hard-to-treat cancer and chronic hepatitis B. Dr Chen goes on to share his…
See our Cookie Privacy Policy Here